CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 328,757	$ 214,437
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	23,572	20,066
Equity in income of unconsolidated entities, net	(383)	(272)
Amortization of stock-based compensation	24,327	15,012
Charges for impairments and lot option abandonments	2,444	12,675
Fair value adjustment on mortgage loans held for sale	(758)	0
Gain on increase in carrying amount of investment	(3,495)	0
Changes in assets and liabilities:
Real estate inventories	(74,485)	(247,846)
Mortgage loans held for sale	(79,313)	0
Receivables	110,911	50,043
Other assets	(9,527)	1
Accounts payable	10,381	(7,093)
Accrued expenses and other liabilities	3,332	67,773
Net cash provided by operating activities	335,763	124,797
Cash flows from investing activities:
Purchases of property and equipment	(18,933)	(19,136)
Proceeds from investment	717	0
Net investments in unconsolidated entities	(24,789)	(6,434)
Distributions from unconsolidated entities	17,289	0
Net cash used in investing activities	(25,716)	(25,570)
Cash flows from financing activities:
Borrowings from loans payable	420	910
Repayment of loans payable and senior notes	(462,844)	0
Borrowings on mortgage repurchase facilities	282,400	0
Repayments on mortgage repurchase facilities	(206,935)	0
Distributions to noncontrolling interests	(3,877)	(6,955)
Proceeds from issuance of common stock under share-based awards	1,041	518
Tax withholding paid on behalf of employees for share-based awards	(16,612)	(9,802)
Share repurchases, excluding excise tax	(96,636)	(124,523)
Net cash used in financing activities	(503,043)	(139,852)
Net decrease in cash and cash equivalents	(192,996)	(40,625)
Cash and cash equivalents–beginning of period	868,953	889,664
Cash and cash equivalents–end of period	$ 675,957	$ 849,039